Prevalence of Drug-Resistance Mutations and Non-Subtype B Strains Among HIV-Infected Infants From New York State
- 15 August 2006
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 42 (5) , 614-619
- https://doi.org/10.1097/01.qai.0000225871.87456.e7
Abstract
Summary: Prevalence studies indicate that transmission of drug-resistant HIV has been rising in the adult population, but data from the perinatally infected pediatric population are limited. In this retrospective study, we sequenced the pol region of HIV from perinatally infected infants diagnosed in New York State in 2001-2002. Analyses of drug resistance, subtype diversity, and perinatal antiretroviral exposure were conducted, and the results were compared with those from a previous study of HIV-infected infants identified in 1998-1999. Eight of 42 infants (19.1%) had provirus carrying at least 1 drug-resistance mutation, an increase of 58% over the 1998-1999 results. Mutations conferring resistance to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors were detected in 7.1%, 11.9%, and 2.4% of specimens, respectively. Consistent with previous results, perinatal antiretroviral exposure was not associated with drug resistance (P = 0.70). Phylogenetic analysis indicated that 16.7% of infants were infected with a non-subtype B strain of HIV. It seems that drug-resistant and non-subtype B strains of HIV are becoming increasingly common in the perinatally infected population. Our results highlight the value of resistance testing for all HIV-infected infants upon diagnosis and the need to consider subtype diversity in diagnostic and treatment strategies.Keywords
This publication has 31 references indexed in Scilit:
- Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical ManagementThe Journal of Infectious Diseases, 2005
- Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohortAIDS, 2003
- Genotype resistance profiles in patients failing an NNRTI‐containing regimen, and modifications after stopping NNRTI therapyJournal of Clinical Laboratory Analysis, 2002
- Primary Genotypic and Phenotypic HIV-1 Drug Resistance in Recent Seroconverters in MadridJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United StatesRevised November 3, 2000HIV Research & Clinical Practice, 2001
- Presence of Human Immunodeficiency Virus (HIV) Type 1, Group M, Non‐B Subtypes, Bronx, New York: A Sentinel Site for Monitoring HIV Genetic Diversity in the United StatesThe Journal of Infectious Diseases, 2000
- Mother-to-Infant Transmission of the Human Immunodeficiency Virus during Primary InfectionNew England Journal of Medicine, 1999
- Vertical Transmission of HIV in New York State: A Basis for Statewide Testing of NewbornsAIDS Patient Care and STDs, 1997
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Long-Term Persistence of Zidovudine Resistance Mutations in Plasma Isolates of Human Immunodeficiency Virus Type 1 of Dideoxyinosine-Treated Patients Removed from Zidovudine TherapyThe Journal of Infectious Diseases, 1994